Navigation Links
Study supports century-old cancer theory

A Yale study recommends that oncology researchers consider the 100-year-old theory that tumor cell hybridization with white blood cells as a major reason cancer metastasizes.//

'Cancer cells exhibit a remarkable number of traits normally attributed to white blood cells known as macrophages, including the ability to migrate to lymph nodes and distant organs and to form a new blood supply,' said lead author John Pawelek in Yale`s school of medicine. 'Our data indicate they do this by hybridizing with macrophages.'

Pawelek said the idea of white blood cells hybridizing with tumor cells is not new. During the early 1900`s the German pathologist Otto Aichel proposed metastasis is caused by cancer cells fusing with macrophages.'There is now evidence to support all aspects of his proposition,' he says. Pawelek.

'Macrophages are among the most motile cells we have. By co-opting the macrophage`s ability to move, the hybrid is very different from the original cancer cell. It is able to migrate away from the primary site of tumor formation and take up residence in other areas of the body while it continues to divide.'

The study appears in the December issue of Lancet Oncology.
'"/>




Page: 1

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ataplexy is a sudden temporary loss of muscle tone... emotional states like laughter or anger. Cataplex... a compulsive disorder to fall asleep. In narcole... and the person has an irresistible urge to sleep ...
...ccording to a study published in the February 1st ...n are common, and often more frequent than in adul...or parents to take an active approach in helping t... consult with their child’s pediatrician, and for ...
...llergic reactions to hair dye are increasing as mo...hers.// This can lead to dermatitis on the face a...ore than two thirds of hair dyes currently contain...d other related agents. During the 20th century, a...
...DT or dichloro diphenyl trichloroethane is the bes...is is still found in the waters of Los Angles coun... its ban. U.S. Environment Protection Agency relea... DDT in the sea is due to the dumping of this subs...
Other Medicine News:Health News:Cataplexy During Status Cataplecticus Resembles REM Sleep 2Health News:Parasomnias are Common in Children: Study 2
(Date:9/4/2008)...ctice Bulletin for Obstetrician-Gynecologists Stat...e Change-Minimally Invasive Interventional,Radiolo...ith Uterine,Fibroids, FAIRFAX, Va., Sept. 4 /PRNe...l Radiology, a national organization of nearly 4,5...nals dedicated to improving health,care through mi...
(Date:9/4/2008)... Updated Survival Data for Ipilimumab to be Pr...stCall/ -- Medarex, Inc.,(Nasdaq: MEDX ) announce...b,an investigational anti-CTLA-4 antibody, in mel...ions at the 33rd Congress of the European Society,...2-16, 2008 in Stockholm.,Many of the following abs...
(Date:9/3/2008)...NEY, Australia, Sept. 4 /Xinhua-PRNewswire-FirstCa... Nasdaq: PXSL) today announced,that it has enrolle...3,clinical trial evaluating Bronchitol in cystic f...nducted in 41 hospitals across North,America, Arge...before,Pharmaxis seeks approval to market Bronchit...
(Date:9/3/2008)...ong term follow up results from chronically infect...d positive data obtained earlier in 2008, - Stud... and long-term antiviral effect of therapeu... and strongly support move into a second generatio...C31(R) acting through TLR ...
Breaking Medicine Technology:Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Research suggests parts of UK could be too hot for wine making by 2080 3441 1Research suggests parts of UK could be too hot for wine making by 2080 3441 2New unifying theory of lasers advanced by physicists 5648 1New unifying theory of lasers advanced by physicists 5648 2GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation 20346 1GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation 20346 2GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation 20346 3WuXi PharmaTech Announces First Quarter 2008 Results 5647 1WuXi PharmaTech Announces First Quarter 2008 Results 5647 2WuXi PharmaTech Announces First Quarter 2008 Results 5647 3WuXi PharmaTech Announces First Quarter 2008 Results 5647 4WuXi PharmaTech Announces First Quarter 2008 Results 5647 5WuXi PharmaTech Announces First Quarter 2008 Results 5647 6WuXi PharmaTech Announces First Quarter 2008 Results 5647 7WuXi PharmaTech Announces First Quarter 2008 Results 5647 8WuXi PharmaTech Announces First Quarter 2008 Results 5647 9WuXi PharmaTech Announces First Quarter 2008 Results 5647 10WuXi PharmaTech Announces First Quarter 2008 Results 5647 11
...ORD, Conn.--(BUSINESS WIRE)--Jun 25, 2007 - Neurog...tive top-line,results from two dose-ranging, Phase...ith the Company,s proprietary insomnia agent,NG2-... Multiple,formulations were studied in each trial ...p onset and maintenance of sleep,through the night...
...OUTH MEETING, Pa., June 25, 2007 /PRNewswire-First...data from a preclinical,study of trodusquemine (MS...d during the American Diabetes Association (ADA) 6.... Dr. Kristen Lantz,Genaera research scientist an...dusquemine is a Multiple Pathway Inhibitor that,Ca...
Other Medicine Technology:Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 2Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 3Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 4Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 5Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 6Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 7Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 8Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 2Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 3Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 4
The MD Coder is simply more than a reference guide: it is a handheld solution for accurate coding and patient tracking for both individual physicians and small practice groups. MD Coder v6.0 now come
Integrated patient tracking and billing. This product contains the complete Handheld application, a complete Desktop application, and complete CPT™ and ICD-9-CM codes licensed from the AMA. Desi
PharmD ToolBox is an advanced medical calculator and rapid reference for Emergency, Pediatric Dosing and Critical Care for PharmDs. This product is a logical complement to other PDA reference product
iFacts™ is the handheld version of Drug Interaction Facts, a drug interaction analyzer covering thousands of brand and generic drugs. iFacts™ enables the practitioner to refer to accurate a
Medicine Products: